Off-label drug in the newborn
The lack of specific drugs and labelling recommendations for the neonatal population is a long-standing problem throughout the world. With the introduction of the Paediatric Regulation in 2007, in Europe tangible steps have been made to increase clinical research in children, but only a limited numb...
Saved in:
Main Author: | Laura Cuzzolin (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2014-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Off-label prescription of drugs at hospital
by: Vicente Arocas Casañ, et al.
Published: (2016) -
Off-label and unlicensed drugs in neonatology
by: Segundo Rite-Gracia, et al.
Published: (2021) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China
by: Weilan Wang, et al.
Published: (2013) -
Off-Label and Off-NCCN Guidelines Uses of Antineoplastic Drugs in China.
by: Weilan Wang, et al.
Published: (2013) -
Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
by: Laura Goedel dos Santos, et al.
Published: (2023)